Ketorolac as an Adjuvant Agent for Postoperative Pain Control Following Arthroscopic ACL Surgery

Completed · Phase 3

Conditions studied: ACL Injury, Postoperative Pain

In brief

1. The investigators aim to examine the use of IV and oral ketorolac as an adjunctive agent to the standard of care pain protocol for postoperative pain control following ACL reconstruction surgery. 2. The investigators hypothesize that the use of IV and oral ketorolac in addition to the standard of care pain protocol will reduce postoperative opioid consumption following ACL reconstruction surgery.

Key facts

Study ID

NCT04246554

Run by

University Hospitals Cleveland Medical Center

People needed

49

Starts

2019-05-21

Expected to finish

2021-01-01

Last updated by the study team

2021-12-21

Who can join

Age: 18 and older, up to 89. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Patients between 18 and 89 years old
• Patients undergoing primary anterior cruciate ligament (ACL) reconstruction surgery

You may not qualify if…

• Patients below age 18 or above age 89
• Illiterate or non-English speaking individuals
• Patients with contraindications to Ketorolac
• History of chronic alcohol or drug abuse
• Chronic use of psychotropic or analgesic drugs
• Known peptic ulcer disease or bleeding diasthesis
• Renal dysfunction (estimated glomerular filtration rate < 50 mL/min/1.73m2)
• Breastfeeding women
• Pregnant women

Where it is running

• UH Cleveland Medical Center — Cleveland, Ohio, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.